Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Emcure Pharmaceuticals Limited ( (IN:EMCURE) ) just unveiled an update.
Emcure Pharmaceuticals has informed the stock exchanges that it has received a confirmation certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025. The RTA has confirmed that all securities received for dematerialisation during the quarter were duly processed, accepted or rejected, listed on the appropriate stock exchanges, and that the corresponding physical certificates were cancelled and the depositories were recorded as the registered owners within the prescribed timelines, underscoring Emcure’s ongoing compliance with securities market regulations and safeguarding of shareholder interests.
More about Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited is an Indian pharmaceutical company headquartered in Pune, Maharashtra, operating in the healthcare sector. It is involved in the development, manufacturing and marketing of a range of pharmaceutical products, serving domestic and international markets through its presence on major Indian stock exchanges.
Average Trading Volume: 100,786
Technical Sentiment Signal: Buy
Current Market Cap: 282.9B INR
Learn more about EMCURE stock on TipRanks’ Stock Analysis page.